Johnson & Johnson (JNJ) Equity Average (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Equity Average data on file, last reported at $81.4 billion in Q1 2026.

• Quarterly Equity Average rose 8.78% year-over-year to $81.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.4 billion (up 8.78% YoY) and the FY2025 annual result came in at $76.5 billion, up 9.1% from the prior year.
• Equity Average advanced to $81.4 billion in Q1 2026 per JNJ's latest filing, from $80.4 billion in the prior quarter.
• The five-year high for Equity Average was $81.4 billion in Q1 2026, with the low at $69.4 billion in Q1 2024.
• Average Equity Average over 5 years is $74.5 billion, with a median of $74.1 billion recorded in 2022.
• Year-over-year, Equity Average gained 15.2% in 2022 and decreased 7.53% in 2023.
• Johnson & Johnson's Equity Average stood at $75.5 billion in 2022, then decreased by 7.26% to $70.0 billion in 2023, then rose by 1.18% to $70.8 billion in 2024, then grew by 13.54% to $80.4 billion in 2025, then gained by 1.19% to $81.4 billion in 2026.
• Business Quant data shows JNJ's Equity Average at $81.4 billion in Q1 2026, $80.4 billion in Q4 2025, and $78.9 billion in Q3 2025.